Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Medicana Avcilar offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 1995, the JCI hospital is located in Istanbul, Turkey, with 63 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
Asian Institute of Medical Sciences offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2010, the NABL, NABH hospital is located in Faridabad, India, with 425 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
With advanced orthopaedic and cartilage-care infrastructure, Apollo Hospital International Limited offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2003, the NABH, JCI hospital is located in Ahmedabad, India, and has 300 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Manipal Hospital, Gurugram offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2008, the NABL, NABH hospital is situated in Gurgaon, India, with 380 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Manipal Hospitals Goa, Dona Paula provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1994, the NABH hospital is based in Panjim, India, with 235 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Metro Hospital provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1997, the NABL, NABH, ISO hospital is based in Noida, India, with 289 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
Sharda Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2005, the NABH hospital is located in Noida, India, with 1200 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
Delhi, India
With advanced orthopaedic and cartilage-care infrastructure, Fortis Flt. Lt. Rajan Dhall Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2006, the NABH hospital is located in Delhi, India, and has 162 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
At Acibadem Altunizade Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2017, the JCI, ISO hospital is located in Istanbul, Turkey, and has 350 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
With advanced orthopaedic and cartilage-care infrastructure, Sheba Medical Center offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1948, the JCI hospital is located in Ramat Gan, Israel, and has 1900 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Herzliya Medical Center provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1983, the hospital is based in Herzliya, Israel, with 120 beds and services for domestic and international patients.
During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.
At Burjeel Hospital, Abu Dhabi, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2012, the JCI hospital is located in Abu Dhabi, United Arab Emirates, and has 209 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
At American Oncology Institute, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2013, the NABH hospital is located in Hyderabad, India, and has 150 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
With advanced orthopaedic and cartilage-care infrastructure, Acibadem University Hospital Atakent offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2014, the JCI hospital is located in Istanbul, Turkey, and has 278 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
At Iranian Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 1970, the hospital is located in Dubai, United Arab Emirates, and has 220 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
